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Abstract 
Purpose: To report a case of a large anterior retinal capillary hemangioma (RCH) treated 
successfully with photodynamic therapy (PDT).  
Methods: Case report.  
Results: A 12-mm-large RCH located in the anterior retina, with vision-threatening exudative 
complications that had not responded to cryotherapy and repeated laser photocoagulations, 
was treated with PDT using verteporfin. Exudation regressed and tumor growth arrested 
after treatment.  
Conclusion: PDT can be delivered effectively to a lesion in the anterior retina and should be 
included as an option for treating anteriorly located RCH when conventional cryotherapy 
and laser photocoagulation fail. 
 
Introduction 
Retinal capillary hemangiomas (RCH) are uncommon benign vascular tumors of the 
retina. Small peripheral RCH can usually be treated successfully by laser 
photocoagulation of the lesion and the afferent arteriole, with or without cryotherapy. 
Effective treatment using photodynamic therapy (PDT) for lesions in the posterior pole 
has also been documented [1]. We report a case of a large peripheral RCH treated with 
PDT after treatment with laser and cryotherapy had failed. To our knowledge, this is 
the first reported use of PDT in an anteriorly located RCH not associated with von 
Hippel-Lindau disease.  
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Case Report 
A 29-year-old female presented with a 1-month history of blurred vision in her right eye. At 
presentation, her best-corrected visual acuity (BCVA) was 20/40. Examination showed a grade-1 
epiretinal membrane at the macula and a small RCH in the peripheral retina near the ora serrata at 12 
o’clock (fig. 1a). Systemic investigations showed no evidence of von Hippel-Lindau disease. BCVA 
improved to 20/28 after surgical removal of the epiretinal membrane. One year after the operation, 
her BCVA dropped to 20/100. There was a significant increase in the size of the RCH (largest diameter 
up to 12 mm), with the surrounding subretinal fluid (SRF) and exudation extended to the macula (fig. 
1b, c). A posterior subcapsular cataract was also noted. Subsequently, the patient underwent 
phacoemulsification with intra-ocular lens implantation and cryotherapy to the RCH. Repeated 
sessions of focal laser ablation to the feeder vessels were performed but they failed to control the 
exudation. After discussion of the treatment options with the patient, standard PDT was performed 
using a verteporfin infusion at a dose of 6 mg/m2 body surface area for 10 min. Five minutes after 
completion of the infusion, light exposure was performed with a diode laser (689 nm) at an intensity 
of 600 mW/cm2. Using a Volk SuperQuad® 160 diode laser lens, the whole RCH was covered with two 
successive confluent burns with spot sizes measuring 6,400 and 6,200 μm, respectively. Laser was 
applied for 83 s for each treatment spot (power: 50 J/cm2). Two days after PDT, there was a 
significant increase in the surrounding SRF that resulted in exudative detachment of the superior 
retina and macula. The exudation resolved spontaneously in 5 days. Five months after PDT, the SRF 
surrounding the RCH resolved completely with a reduction in size of the RCH (fig. 2). The final BCVA 
in this patient was 20/20. 
Discussion 
Previously, PDT had been reserved for treating RCH in the posterior retina and 
peripapillary region when laser photocoagulation and cryotherapy were considered 
ineffective or unsafe to apply [2]. Due to the original design of PDT for the treatment of 
macular choroidal neovascularization, the dynamic field of view of commercially 
available PDT laser lenses is within the range of 133–137°, which is not adequate to 
cover lesions in the extreme periphery. As a result, laser photocoagulation and 
cryotherapy have remained treatment options for peripherally located RCH in most 
cases. When such conventional treatments are ineffective, more aggressive modalities, 
such as radioactive plaque therapy or surgical excision, would need to be considered [3, 
4]. Our case has demonstrated that PDT can be delivered effectively to a lesion in the 
anterior retina using a wide-field diode laser contact lens. The positive treatment 
response was evidenced by tumor shrinkage and resolution of exudation. Transient 
increase in exudation from RCH following PDT has been documented previously [5]. 
Such exudation is usually self-limiting in nature and had no effect on the final visual 
outcome in our case. In summary, our case has illustrated that PDT is an effective 
treatment for large RCH in the anterior retina when conventional laser and cryotherapy 
have failed to control the disease. 
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Fig. 1. a Appearance of the RCH at presentation when examined under a Goldmann 3-mirror lens. It 
was located near the ora serrata with minimal surrounding exudates. b Fundus photo of the right eye 
shows the subsequent enlargement of the RCH and the associated increase in the amount of SRF and 
exudates. The largest diameter of the RCH measured up to 12 mm. c SRF and exudates from the RCH 
extended to involve the macula. 
 
 
 
Fig. 2. Fundus photo taken 5 months after PDT shows the complete resolution of SRF and exudates. 
Chorioretinal scars from previous laser photocoagulation of the feeder vessels can be seen in the 
superior quadrant. The RCH reduced in size and cannot be visualized in the area covered in this 
photo. 
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